The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring ...

The new results helped boost Moderna’s stock by more than 4% in early trading June 30, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

Many Indian firms chase quick returns, rely on imported technology, and underinvest in research. But innovation needs ...

Health Minister says all corporate and private companies will be directed to mandatorily provide annual health screening for ...

The Karnataka government on Monday decided to treat sudden deaths as “notifiable disease” and conduct postmortem in such cases. State Health Minister Dinesh Gundu Rao said there will be more screening ...

The Karnataka government will declare sudden deaths in individuals under 45 as a notifiable disease, amid concerns over potential links to Covid-19 vaccines.

The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...

The six groups -- including the American Academy of Pediatrics (AAP), the American College of Physicians (ACP) and the ...

NPR's Pien Huang speaks with pediatrician Alexandra Cvijanovich and Professor Jason L. Schwartz about trying to shore up trust about vaccines.

The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.